MargheRITA (Remote Intelligence for Therapeutic Adherence)

NACompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

June 4, 2022

Primary Completion Date

January 16, 2023

Study Completion Date

January 16, 2023

Conditions
Multiple MyelomaSolitary PlasmacytomaAmyloidosisChronic Myeloid LeukemiaChronic Lymphocytic LeukemiaT Cell Non-Hodgkin LymphomaLymphocytic LymphomaHodgkin LymphomaB-cell Non Hodgkin LymphomaAcute Myeloid LeukemiaMyelodysplasiaChronic Myeloproliferative DisorderTreatment AdherenceTreatment Adherence and Compliance
Interventions
DEVICE

RITA (App)

"The RITA Remote Intelligence for Therapeutic Adherence application was designed, on the doctor's side, as a support for the management of the onco-hematological patient and, on the patient's side, as a first aid tool for the management of the most common problems, as well as an efficient and non-invasive means of communication with the doctor. The system also allows the caregiver and general practitioner to be included in the communication group.~The added value of the app consists in improving the relationship between the patient and the doctor, creating an effective communication channel, increasing the safety the patient has when facing his difficult path, reducing the number of visits to the facility and, in general, making those visits more efficient, thus creating savings both in terms of time and resources."

Trial Locations (1)

20153

ASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologiche P.O. San Carlo, Milan

All Listed Sponsors
lead

Advice Pharma Group srl

INDUSTRY